Comparison between patients with N0 cancer and those with lymph node metastasis revealed that CEA also showed low AUCs of 0.540 and sensitivity of 8.7 per cent in patients with lymph node metastasis. Here, CEACAM5 is linked to metastatic malignant neoplasm in the lymph nodes.